These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
327 related articles for article (PubMed ID: 24063904)
21. Expected years of life lost for six potentially preventable cancers in the United States. Liu PH; Wang JD; Keating NL Prev Med; 2013 May; 56(5):309-13. PubMed ID: 23428566 [TBL] [Abstract][Full Text] [Related]
22. Trends in educational inequalities in mortality, seven types of cancers, Norway 1971-2002. Elstad JI; Torstensrud R; Lyngstad TH; Kravdal O Eur J Public Health; 2012 Dec; 22(6):771-6. PubMed ID: 22167478 [TBL] [Abstract][Full Text] [Related]
23. Second primary cancers in the Vaud and Neuchâtel Cancer Registries. Levi F; Randimbison L; Rafael BM; Manuela MC; La Vecchia C Eur J Cancer Prev; 2015 Mar; 24(2):150-4. PubMed ID: 25397586 [TBL] [Abstract][Full Text] [Related]
24. Impact of second primary esophageal or lung cancer on survival of patients with head and neck cancer. Chen MC; Huang WC; Chan CH; Chen PT; Lee KD Oral Oncol; 2010 Apr; 46(4):249-54. PubMed ID: 20138797 [TBL] [Abstract][Full Text] [Related]
25. Different survival analysis methods for measuring long-term outcomes of Indigenous and non-Indigenous Australian cancer patients in the presence and absence of competing risks. He VY; Condon JR; Baade PD; Zhang X; Zhao Y Popul Health Metr; 2017 Jan; 15(1):1. PubMed ID: 28095862 [TBL] [Abstract][Full Text] [Related]
26. "Just Another Statistic". Machtay M; Glatstein E Oncologist; 1998; 3(3):III-IV. PubMed ID: 10388105 [TBL] [Abstract][Full Text] [Related]
27. Cost of care for elderly cancer patients in the United States. Yabroff KR; Lamont EB; Mariotto A; Warren JL; Topor M; Meekins A; Brown ML J Natl Cancer Inst; 2008 May; 100(9):630-41. PubMed ID: 18445825 [TBL] [Abstract][Full Text] [Related]
28. Cancer survival in Kentucky and health insurance coverage. McDavid K; Tucker TC; Sloggett A; Coleman MP Arch Intern Med; 2003 Oct; 163(18):2135-44. PubMed ID: 14557210 [TBL] [Abstract][Full Text] [Related]
29. Evidence of increasing mortality with longer diagnostic intervals for five common cancers: a cohort study in primary care. Tørring ML; Frydenberg M; Hansen RP; Olesen F; Vedsted P Eur J Cancer; 2013 Jun; 49(9):2187-98. PubMed ID: 23453935 [TBL] [Abstract][Full Text] [Related]
30. The application of cure models in the presence of competing risks: a tool for improved risk communication in population-based cancer patient survival. Eloranta S; Lambert PC; Andersson TM; Björkholm M; Dickman PW Epidemiology; 2014 Sep; 25(5):742-8. PubMed ID: 25036430 [TBL] [Abstract][Full Text] [Related]
31. Survival of cancer patients in France: a population-based study from The Association of the French Cancer Registries (FRANCIM). Bossard N; Velten M; Remontet L; Belot A; Maarouf N; Bouvier AM; Guizard AV; Tretarre B; Launoy G; Colonna M; Danzon A; Molinie F; Troussard X; Bourdon-Raverdy N; Carli PM; Jaffré A; Bessaguet C; Sauleau E; Schvartz C; Arveux P; Maynadié M; Grosclaude P; Estève J; Faivre J Eur J Cancer; 2007 Jan; 43(1):149-60. PubMed ID: 17084622 [TBL] [Abstract][Full Text] [Related]
32. Stage at diagnosis and early mortality from cancer in England. McPhail S; Johnson S; Greenberg D; Peake M; Rous B Br J Cancer; 2015 Mar; 112 Suppl 1(Suppl 1):S108-15. PubMed ID: 25734389 [TBL] [Abstract][Full Text] [Related]
33. Crude probability of death for cancer patients by spread of disease in New South Wales, Australia 1985 to 2014. Yu XQ; Dasgupta P; Kahn C; Kou K; Cramb S; Baade P Cancer Med; 2021 Jun; 10(11):3524-3532. PubMed ID: 33960140 [TBL] [Abstract][Full Text] [Related]
34. Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017. Hristova L; Hakama M Acta Oncol; 1997; 36 Suppl 9():1-60. PubMed ID: 9143316 [TBL] [Abstract][Full Text] [Related]
35. Trends in survival of patients diagnosed with male genital cancers in the Nordic countries 1964-2003 followed up until the end of 2006. Bray F; Klint A; Gislum M; Hakulinen T; Engholm G; Tryggvadóttir L; Storm HH Acta Oncol; 2010 Jun; 49(5):644-54. PubMed ID: 20151937 [TBL] [Abstract][Full Text] [Related]
36. Temporal trends in net and crude probability of death from cancer and other causes in the Australian population, 1984-2013. Dasgupta P; Cramb S; Kou K; Yu XQ; Baade PD Cancer Epidemiol; 2019 Oct; 62():101568. PubMed ID: 31330423 [TBL] [Abstract][Full Text] [Related]
37. Incorporating competing risk theory into evaluations of changes in cancer survival: making the most of cause of death and routinely linked sociodemographic data. Wright CM; Nowak AK; Halkett G; Moorin RE BMC Public Health; 2020 Jun; 20(1):1002. PubMed ID: 32586298 [TBL] [Abstract][Full Text] [Related]
38. Timely disclosure of progress in long-term cancer survival: the boomerang method substantially improved estimates in a comparative study. Brenner H; Jansen L J Clin Epidemiol; 2016 Feb; 70():224-32. PubMed ID: 26456902 [TBL] [Abstract][Full Text] [Related]
39. Unbiased estimates of long-term net survival of solid cancers in France. Jooste V; Grosclaude P; Remontet L; Launoy G; Baldi I; Molinié F; Arveux P; Bossard N; Bouvier AM; Colonna M; Int J Cancer; 2013 May; 132(10):2370-7. PubMed ID: 23001495 [TBL] [Abstract][Full Text] [Related]
40. Estimating cure and risk of death from other causes of cancer patients: EUROCARE-6 data on head & neck, colorectal, and breast cancers. Botta L; Capocaccia R; Bernasconi A; Rossi S; Galceran J; Maso LD; Lepage C; Molinié F; Bouvier AM; Marcos-Gragera R; Vener C; Guevara M; Murray D; Ragusa R; Gatta G; Jooste V; Eur J Cancer; 2024 Sep; 208():114187. PubMed ID: 39013266 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]